ms FAITH CRISTOL esq

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills), self-referral abuses relating to anatomic pathology (no specific bills), and Patient Protection and Affordable Care Act implementation.

Oversight of laboratory services and genetic information and testing to include the Food and Drug Administration Safety and Innovation Act (Public Law No: 112-144).

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule and federal budget negotiations (no specific bills), self-referral abuses relating to anatomic pathology (no specific bills), and Patient Protection and Affordable Care Act implementation.

Oversight of laboratory services and genetic information and testing to include the Food and Drug Administration Safety and Innovation Act (Public Law No: 112-144).

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule and federal budget negotiations (no specific bills), self-referral abuses relating to anatomic pathology (no specific bills), and Patient Protection and Affordable Care Act implementation.

Oversight of laboratory services and genetic information and testing to include the Food and Drug Administration Safety and Innovation Act (Public Law No: 112-144).

Oversight of laboratory services and genetic information and testing to include the Modernizing Laboratory Test Standards for Patients Act of 2011 (H.R. 3207), the Food and Drug Administration Reform Act of 2012 (H.R. 5651), and the Food and Drug Administration Safety and Innovation Act (S. 3187).

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule and federal budget negotiations (no specific bills), self-referral abuses relating to anatomic pathology (no specific bills), and Patient Protection and Affordable Care Act implementation.

Oversight of laboratory services and genetic information and testing, to include the Modernizing Laboratory Test Standards for Patients Act (H.R. 3207), Food and Drug Administration Reform Act of 2012 (H.R. 5651), and Food and Drug Administration Safety and Innovation Act (S. 3187); clinical laboratory workforce shortage issues; Patient Protection and Affordable Care Act implementation.

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills); and self-referral abuses relating to anatomic pathology (no specific bills); and reimbursement and oversight of clinical laboratory services (no specific bills).

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule; provisions in the Affordable Care Act and federal budget negotiations to include the Middle Class Tax Relief and Job Creation Act of 2012 (H.R. 3630); self-referral abuses relating to anatomic pathology (no specific bills); and reimbursement and oversight of clinical laboratory services (no specific bills).

Oversight of laboratory services and genetic information and testing, to include the Modernizing Laboratory Test Standards for Patients Act (H.R. 3207); the Gestational Diabetes Act (H.R. 2194, S. 1221).

See quarterly LD-2 filings.

See quarterly LD-2 filings.

Oversight of laboratory services and genetic information and testing, to include the Modernizing Laboratory Test Standards for Patients Act (H.R. 3207); the Gestational Diabetes Act (H.R. 2194, S. 1221).

Medicare reimbursement related to the 2011 Physician Fee Schedule, provisions in the Affordable Care Act and federal budget negotiations, to include the Temporary Payroll Tax Cut Continuation Act of 2011 (H.R. 3765); self-referral abuses relating to anatomic pathology (no specific bills); reimbursement and oversight of clinical laboratory services (no specific bills).

Medicare reimbursement related to the 2011 Physician Fee Schedule, provisions in the Affordable Care Act and federal budget negotiations (no specific bills); self-referral abuses relating to anatomic pathology (no specific bills); reimbursement and oversight of clinical laboratory services (no specific bills); and S. 365, Budget Control Act of 2011.

Oversight of laboratory services and genetic information and testing (no specific bills); the Gestational Diabetes Act (H.R. 2194, S. 1221).

Oversight of laboratory services and genetic information and testing (no specific bills); the Gestational Diabetes Act (H.R. 2194, S. 1221).

Medicare reimbursement related to the 2011 Physician Fee Schedule, provisions in the Affordable Care Act and federal budget negotiations (no specific bills); self-referral abuses relating to anatomic pathology (no specific bills); and reimbursement and oversight of clinical laboratory services (no specific bills).

Oversight of laboratory services and genetic information and testing (no specific bills); the Gestational Diabetes Act (H.R. 2194, S. 1221).

Medicare reimbursement related to the 2011 Physician Fee Schedule, provisions in the Affordable Care Act and federal budget negotiations (no specific bills); self-referral abuses relating to anatomic pathology (no specific bills); and reimbursement and oversight of clinical laboratory services (no specific bills).

Medicare reimbursement related to the 2011 Physician Fee Schedule and provisions in the Affordable Care Act; self-referral abuses relating to anatomic pathology (no specific bills); and oversight over laboratory services (no specific bills), genetic information and testing (no specific bills).

Medicare reimbursement related to the 2011 Physician Fee Schedule and provisions in the Affordable Care Act; self-referral abuses relating to anatomic pathology (no specific bills); and oversight over laboratory services (no specific bills), genetic information and testing (no specific bills).

Medicare reimbursement related to the 2011 Physician Fee Schedule and provisions in the Affordable Care Act (Medicare and Medicaid Extenders Act of 2010 (P.L. 111-309)); self-referral abuses relating to anatomic pathology (no specific bills), and oversight over laboratory services (no specific bills), genetic information and testing (no specific bills).

Health care reform including wellness issues and entities created by the Affordable Care Act; laboratory issues include results to patients (no specific bills), self-referral abuses relating to anatomic pathology (no specific bills), statutory authority of oversight over laboratory services (no specific bills), genetic information and testing (no specific bills). Regulation of health and health information systems and incentives for use of same (no specific bills).

Health care reform including wellness issues; laboratory issues include results to patients, self-referral abuses relating to anatomic pathology, statutory authority of oversight over laboratory services, genetic information and testing (no specific bills). Regulation of health and health information systems and incentives for use of same (no specific bills).

Health care reform including clinical laboratory payment issues; technical component grandfather extension (H.R. 2847, Hiring Incentives to Restore Employment Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4213, American Workers, State, and Business Relief Act of 2010; H.R. 4872, Health Care and Education Reconciliation Act of 2010); continued on next page. Continued: sustainable growth rate extension (H.R. 3961, Medicare Physician Payment Reform Act of 2009; H.R. 4691, Temporary Extension Act of 2010; H.R. 4851, Continuing Extension Act); laboratory issues (no specific bills) include results to patients, self-referral abuses relating to anatomic pathology, statutory authority of laboratory services, genetic information and testing.